ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 188 filers reported holding ADMA BIOLOGICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,393,454 | +5.3% | 5,417,166 | +8.5% | 0.01% | 0.0% |
| Q2 2023 | $18,415,756 | +15.3% | 4,990,720 | +3.4% | 0.01% | +25.0% |
| Q1 2023 | $15,976,098 | -2.2% | 4,826,616 | +14.6% | 0.00% | -20.0% |
| Q4 2022 | $16,340,523 | +96.3% | 4,211,475 | +22.9% | 0.01% | +66.7% |
| Q3 2022 | $8,325,000 | +1232.0% | 3,425,749 | +984.6% | 0.00% | – |
| Q2 2022 | $625,000 | -20.5% | 315,853 | -26.5% | 0.00% | – |
| Q1 2022 | $786,000 | -0.4% | 429,463 | -23.3% | 0.00% | – |
| Q4 2021 | $789,000 | +2445.2% | 559,926 | +3028.8% | 0.00% | – |
| Q1 2021 | $31,000 | +10.7% | 17,896 | +25.2% | 0.00% | – |
| Q4 2020 | $28,000 | -96.1% | 14,294 | -91.2% | 0.00% | – |
| Q3 2019 | $724,000 | +249.8% | 162,632 | +197.2% | 0.00% | – |
| Q1 2019 | $207,000 | +72.5% | 54,729 | +8.8% | 0.00% | – |
| Q4 2018 | $120,000 | -68.5% | 50,307 | -18.1% | 0.00% | – |
| Q3 2018 | $381,000 | +82.3% | 61,406 | +32.7% | 0.00% | – |
| Q2 2018 | $209,000 | – | 46,273 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Velan Capital Investment Management LP | 4,000,000 | $15,520,000 | 13.71% |
| Stonepine Capital Management, LLC | 6,940,000 | $26,927,200 | 11.33% |
| Caligan Partners LP | 2,676,093 | $10,383,241 | 8.64% |
| Altium Capital Management LP | 2,870,000 | $11,135,600 | 5.66% |
| AWM Investment Company, Inc. | 6,015,000 | $23,338,200 | 3.36% |
| EAM Investors, LLC | 1,749,598 | $6,788,440 | 1.40% |
| Perceptive Advisors | 11,900,255 | $46,172,989 | 1.30% |
| EAM Global Investors LLC | 836,323 | $3,244,933 | 0.84% |
| Potomac Capital Management, Inc. | 120,000 | $466 | 0.54% |
| OBERWEIS ASSET MANAGEMENT INC/ | 536,900 | $2,083,172 | 0.44% |